MMJ Recs

JANUARY 6, 2024

In recent years, the landscape of medical marijuana has evolved dramatically, offering patients a diverse array of products tailored to address a myriad of health conditions. From tinctures and edibles to topicals and inhalables, the variety of options can be overwhelming.

Chronic Pain 52

Chronic Pain Topical Marijuana Indica 52

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. About Virpax Pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business.

Marijuana 217

Marijuana Legalization Programs Oil 217

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

SEPTEMBER 6, 2021

GW Pharmaceuticals. For instance, it is very effective in reducing nausea and increasing appetite among chemotherapy patients. Similarly, it is also used in combination with traditional opioid painkillers, which enables patients to reduce the dosage and frequency of opioids significantly and imparts greater pain relief.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Epilepsy Behav. Accessed October 17, 2022. 2021.108514.

CBD 144

CBD Seed-To-Sale Food Access 144

Veriheal

SEPTEMBER 22, 2021

If the proposal — which was sponsored by Rules Committee Chairman Bill Rabon (R) — is enacted into law, patients who are diagnosed with a “debilitating medical condition” could legally gain access to medical cannabis in North Carolina. Home cannabis cultivation, on the other hand, would be forbidden.

Legalization 111

Legalization Patients Cultivation Legislation 111

PrestoDoctor

OCTOBER 13, 2023

Whether you are a medical professional, a patient, or simply someone curious about the world of medical marijuana, this post will provide you with the information you need to make informed decisions about your health. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug. 5, or 10 milligrams of THC.

THC 98

THC Chronic Pain Treatment Conditions 98

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. –(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. The study will take place in Canada with a CTA filing and enrollment of the first patient anticipated by Q2 of 2022. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Canna Law Blog

APRIL 27, 2020

Some related topics we’ve written on are CBD comestibles , CBD pet products , CBD in alcohol , and CBD topicals. We’ve also written about the enforcement actions issued by the FDA to CBD companies, including those issued to CBD companies selling topical products, and on April 23, 2020, the FDA announced its latest round of enforcement.

CBD 60

CBD Topical Oil Treatment 60

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. Epidiolex has received FDA approval to treat Dravet Syndrome and Lennox-Gestaut Syndrome; two very rare forms of epilepsy that manifest in early childhood.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

For example, many anti-anxiety pharmaceuticals are habit-forming, entail significant negative side effects, and can also cause physical problems such as diminished mobility or coordination. Ultimately, cannabis for mental health seems to boil down to questions of individual patient suitability. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Leaf Science

JULY 23, 2019

In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex. Positive health and well-being is routed in a healthy mind and a body free from aches and pains.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Cannabis Law Report

SEPTEMBER 28, 2021

In this case, the patient needs to look for the best ways to treat pain and improve their life quality. Topical Creams. Patients will need to have a prescription from their doctor and most likely will have to go through a consultation with a physician before getting a shot. CBD Products. Acupressure.

Treatment 52

Treatment Chronic Pain Therapy Tincture 52

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Key Topics Covered: Chapter 1 Methodology and Scope. GW Pharmaceuticals, PLC. Chapter 2 Executive Summary.

Recreational 95

Recreational Hemp THC Legalization 95

The Cannigma

MARCH 7, 2022

When CBN was studied without barbiturates (prescription sedative medications typically used for epilepsy), the combination of CBN and THC produced greater sedation together than either cannabinoid alone. It is exploring the treatment of pain from osteoarthritis with cannabinoid ratios – specifically, CBD + CBN and CBD + THC versus placebo.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. Source: The Guardian ). Source: SIPSE.COM ).

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

Cannabis Law Report

OCTOBER 20, 2019

She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. as a Schedule II substance.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Cannabis Law Report

JUNE 20, 2019

But, some patients often use pharmaceutical drugs to reduce symptoms of stress, depression, and anxiety. Many patients experience pain from cancer medication. Multiple sclerosis and epilepsy. Short-term use of medical cannabis helps enhance spasticity symptoms among multiple sclerosis patients.

History 67

History Medicine Chronic Pain Conditions 67

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Miss Marijuana

MAY 17, 2020

A 2010 survey of patients suffering from chronic pain resulted in a 64% decrease in symptoms when treated with medical marijuana. Marijuana has long been a popular mainstay for cancer patients, and for good reason. Natural Pain Relief. Plant-Powered Cancer Treatment. Improved Mental Health. Natural Muscle Relaxant .

Marijuana 52

Marijuana Sleep Treatment Chronic Pain 52

Miss Marijuana

MAY 17, 2020

A 2010 survey of patients suffering from chronic pain resulted in a 64% decrease in symptoms when treated with medical marijuana. Marijuana has long been a popular mainstay for cancer patients, and for good reason. Natural Pain Relief. Plant-Powered Cancer Treatment. Improved Mental Health. Natural Muscle Relaxant .

Marijuana 52

Marijuana Sleep Treatment Chronic Pain 52

WeedAdvisor

JANUARY 8, 2019

Even if trials were successful, it is safe to say that using marijuana to treat cancer would meet resistance from the pharmaceutical companies and medical communities alike. While research into the topic is rare, it is not non-existent. This is unfortunate, as 9.6 The Endocannabinoid System in Cannabis Cancer Treatment.

Treatment 75

Treatment Research and Development Cannabinoids THC 75

Cannabis Law Report

NOVEMBER 10, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. In October 2021, Virpax announced that a $1.87 For more information, please visit www.virpaxpharma.com.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

FEBRUARY 3, 2022

Patients suffering from chronic diseases, like Parkinson’s, Alzheimer’s, cancer, and many neurological disorders, are administered cannabis. The presence of major key players, pharmaceutical and biotechnology industries worldwide, and their experimental approach drives the cannabis market growth. Gw Pharmaceuticals plc.

Indica 52

Indica Oil Legalization Research and Development 52

Canna Law Blog

NOVEMBER 16, 2021

There are call outs in the bill specifically regarding advertising and promoting cannabis products and protecting minors (I imagine that the Feds will borrow heavily from state regulations that already well cover this topic). Age limits (21). ” SBA fairness.

DEA 90

DEA Business Banking Food 90

Cannabis Law Report

SEPTEMBER 8, 2019

It’s not uncommon for the medical industry to get cannibalized when adult-use marijuana is legalized, because it means patients no longer have to wait for a doctor’s approval and prescription to buy weed. Of course, this production capacity is liable to be bumped up if patient demand merits it. Mexico: $1.02

Pharmaceutical 45

Pharmaceutical Recreational Patients Hash 45

Alchimia

JUNE 20, 2016

That could explain why kids using CBD to treat epilepsy may experience some of the side effects of THC, like sleepiness. Topical application is particularly efficient to treat localized pains or skin problems like acne or psoriasis. CBD crystals , 98% purity. Cannabidiol can also be used via CBD creams, ointments and other compounds.

Medicine 76

Medicine CBD Research and Development Epilepsy 76

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

SEPTEMBER 12, 2021

Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only. Many states that disagreed with the federal approach to cannabis started their own medical marijuana programs, and made it accessible for patients. Consumption methods.

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

MARCH 3, 2020

Hot coffee, friendly staff, and medical cannabis eagerly greet patients and guests on Feburary 15, 2020 at the Grand Opening of MÜV Dispensary on Ninth Avenue in Pensacola, Florida. . We strive to make a firsthand connection with every patient or caretaker to provide them with reliable and effective cannabis based therapies.

Dispensary 64

Dispensary Patients Cannabis Wellness and Beauty 64

The Joint Blog

SEPTEMBER 17, 2020

This is especially exciting for epilepsy patients who suffer from these problems on a regular basis. It is mainly used to treat two rare forms of epilepsy that are very difficult to treat with other methods. Either way, many people will attest to the effectiveness of CBD-based topical treatments.

Oil 26

Oil CBD Blood Pressure Research and Development 26

Cannabis Law Report

JANUARY 24, 2022

where marijuana for recreational use has been legalized, the market has witnessed a dynamic shift of patients from traditional methods or medicine to opting to use marijuana for medical and other purposes. Key Topics Covered: Chapter 1 Methodology and Scope. GW Pharmaceuticals, plc. In countries, such as Canada and the U.S.,

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

The Cannigma

DECEMBER 22, 2021

It doesn’t mean, necessarily, that the market should go to full legalization within a year or two, because it won’t happen so fast, but you can have more patients with other medical indications that were not given cannabis before. Obviously, that means that there are more patients and there are more products to sell.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Green Relief

FEBRUARY 20, 2018

I was first introduced to the topic of Epigenetics in 2008 at a business conference in Florida, and as a medical professional I was immediately intrigued. Using genetic information to formulate a unique cannabis blend can decrease the “trial and error” phase upon starting cannabis, and provide more consistency in improving patient outcomes.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Cannabis Law Report

OCTOBER 17, 2019

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. the form the finished product can take (edibles, topicals, etc.). how the segments are defined (e.g.,

Law 40

Law Seed-To-Sale Hemp Recreational 40